Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors

J Natl Cancer Inst. 1991 Aug 21;83(16):1157-60. doi: 10.1093/jnci/83.16.1157.

Abstract

We examined the progesterone receptor (PgR) gene in tissue from both primary human breast tumors and normal placentas, detecting restriction fragment length polymorphisms (RFLPs) with the restriction endonucleases Pst I/Sst I and HindIII. There was a general agreement of the Pst I and Sst I polymorphisms in any individual tumor, suggesting that they define two alleles in the human PgR locus, one being characterized by a deletion of about 300 base pairs with respect to the other. Both primary human breast tumor specimens (n = 36) and human term placentas (n = 48) displayed similar allele frequencies and typical mendelian distribution of these Pst I/Sst I alleles. The previously reported HindIII PgR RFLP was also investigated in 132 breast tumors. The HindIII PgR gene RFLP did not display typical mendelian distribution in the breast tumors; the factors affecting the HindIII allele frequencies are presently unknown. Neither the HindIII RFLP nor the deletion defined by Pst I and Sst I correlated with PgR expression as determined by a ligand-binding assay, suggesting that neither is related to the heterogeneity of PgR expression seen in breast tumors.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Southern
  • Breast Neoplasms / genetics*
  • DNA, Neoplasm / analysis
  • Deoxyribonuclease HindIII
  • Deoxyribonucleases, Type II Site-Specific
  • Female
  • Humans
  • Placenta / chemistry
  • Polymorphism, Restriction Fragment Length
  • Pregnancy
  • Receptors, Progesterone / genetics*
  • Tumor Cells, Cultured

Substances

  • DNA, Neoplasm
  • Receptors, Progesterone
  • Deoxyribonuclease HindIII
  • endodeoxyribonuclease SacI
  • CTGCAG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific